122 filings
Page 2 of 7
8-K
ic10p
14 Mar 11
SCOLR Pharma, Inc. Receives Deficiency Letter from FDA
12:00am
8-K
8v8gndob
25 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
uc2 4g0d3qg51iccw6q
22 Dec 10
SCOLR Pharma, Inc. Announces Intention to Voluntarily Delist
12:00am
8-K
4jz8ga1lc6t1b
29 Sep 10
SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
12:00am
8-K
hfabtj0
2 Sep 10
SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
12:00am
8-K
xp6te3 11vc5u9txx
14 Jun 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zfw9bd47vnly3j0
6 May 10
Entry into a Material Definitive Agreement
12:00am
8-K
jx3k t0epdpiu
29 Apr 10
SCOLR Pharma, Inc. Reports First Quarter 2010 Financial Results
12:00am
8-K
edx2a4xgg2
28 Apr 10
Regulation FD Disclosure
12:00am
8-K
vy8xc9zci
24 Mar 10
SCOLR Pharma, Inc. Reports 2009 Full-Year Financial Results
12:00am
8-K
d2lrw7h7
24 Mar 10
Termination of a Material Definitive Agreement
12:00am
8-K
63kr7 s83x5t0bf
16 Mar 10
SCOLR Pharma Acquires the Rights to NuprinĀ® from CVS
12:00am
8-K
jl1qo83
15 Mar 10
Entry into a Material Definitive Agreement
12:00am
8-K
y33f44 q33skib4c
8 Mar 10
Regulation FD Disclosure
12:00am
8-K
n5msz
18 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
3rpjte pz
4 Jan 10
Entry into a Material Definitive Agreement
12:00am
8-K
ogd68dyk
16 Dec 09
Departure of Directors or Certain Officers
12:00am
8-K
0qp3ph2
30 Nov 09
SCOLR Pharma, Inc. Receives Notices from NYSE Amex LLC
12:00am
8-K
12rwvk42e6e
25 Nov 09
Entry into a Material Definitive Agreement
12:00am
8-K
7oek75runfl
9 Nov 09
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
12:00am